Pharma Justifies Steep Prices, Plans Fancy Footwork In The Era Of Cures

09 Jan 2018

• By Emily Hayes

BioMarin CMO Geoff Nichol envisions "fancy footwork" in future payer negotiations for groundbreaking hemophilia therapy, during a discussion on value at the 2018 Biotech Showcase meeting, held in conjunction with the J.P. Morgan conference.

Doctor holding out your piggy bank wanting payment/ Your Savings To Pay Bill, insert coins to it,Stethoscope financial checkup or saving for medical insurance costs money plan fee Lifestyle concept

Pharma Justifies Steep Prices, Plans Fancy Footwork In The Era Of Cures

More from Cell Therapies

More from Advanced Therapies